Lucovitaal Obesimed Max

Nom de l'organisation

PK Benelux BV

SRN

NL-MF-000006672

Statut du fabricant

Actif

1 avertissement enregistré — faire défiler le panneau pour tout voir.

• CW999

  Warnings: • Do not chew or bite the tablets; • Keep out of reach of children; • Do not use if the blister package has been damaged. Restrictions on use: Carb & Fat blocker may be used for periods longer than four weeks if you comply with the following restrictions on use: • Obtain medical advice before long-term use of the product; • Do not take medicinal products (e.g. contraceptives), vitamins or essential fatty acids at the same time as Carb & Fatblocker; Oral medication must be taken 1 hour before or 4 hours after using . Carb & Fatblocker. Consult your doctor before using Carb & Fatblocker if you need to take medication at main meal times; • In the event of constipation or other side effects, you should immediately discontinue use and consult a doctor. Side effects: • No harmful side effects are known, but you may experience a temporary feeling of satiety after taking Carb & Fatblocker. This normally disappears after a short time; • Persons with sensitive stomachs or bowels might experience abdominal discomfort, nausea, stomach upset, indigestion, abdominal pain, gas or constipation. If the side effects continue, the dose should be reduced or intake should be discontinued. Contraindications: Do not take Carb & Fatblocker if: • You are hypersensitive or allergic to one of the ingredients; • You suffer or have suffered from gastrointestinal disorders (e.g. acid reflux disease, gastritis, ventricular or duodenal ulcers, Crohn’s disease, ulcerative colitis, diverticulitis), signs of intestinal obstruction (impending or existing mechanical or paralytic ileus), gastroparesis in diabetics with neuropathy, intestinal polyps or existing severe digestive disorders (constipation); • You are taking Warfarin (blood thinner); • You are underweight (Body Mass Index (BMI)<18.5); • You are pregnant or breastfeeding; • Not suitable for babies or infants; • Children and adolescents should use Carb & Fatblocker only after consulting a doctor.

Marché principal en Pays-Bas ; disponible dans 1 pays au total.

Dénomination commerciale

Lucovitaal Obesimed Max

Code d'UDI-DI

D-092843Q2

Basic UDI-DI

B-092843Q2

Numéro de référence/catalogue

092843

Entité d'attribution

EUDAMED

Catégorie de risque

Classe IIa

Législation applicable

MDD [Directive 93/42/CEE relative aux dispositifs médicaux]

Statut

Sur le marché

Quantité

1

Description complémentaire du produit

To reduce the caloric impact and help to treat and prevent obesity and overweight.

URL des informations complémentaires

Aucune URL d'informations complémentaires renseignée par le fabricant.

Dimensions cliniques

Aucune dimension clinique enregistrée pour ce dispositif.

• Numéro de lot
• Date d'expiration
• Date de fabrication
• Numéro de série
• Identification du logiciel

D-092843Q2

La génération de DataMatrix prend en charge les IUD émis par GS1. La prise en charge HIBCC / ICCBBA arrive bientôt.

Nomenclature européenne des dispositifs médicaux — la classification produit UE attribuée à ce dispositif.

• G0402ORALLY ADMINISTERED DEVICES FOR APPETITE CONTROL AND REDUCTION OF INTESTINAL ABSORPTION